Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 

7 Binary Options

 

Enter Stock Symbol:  

Neurotrope Inc (NTRP)

6.75 0.09 (1.35%)

11-24 13:00

Open:

6.68

Pre. Close:

6.66

High:

6.75

Low:

6.43

Volume:

11,229

Market Cap:

53M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

-

-

Low:

-

-

Close:

-

-

Technical analysis  (as of: 2017-11-24 1:58:23 PM)

Overall:

      

Stoxline posted a BUY today, upgraded from lower rating. This stock seems to be ready for a new bullish move. If you bought, continue to hold stock until SELL signal. You are relatively safe to buy now, a new upward move is expected.

Target:

Six months: 9.44     One year: 11.02

Support:

Support1: 5.54    Support2: 3.97

Resistance:

Resistance1: 8.08    Resistance2: 9.44

Pivot:

5.32

Moving Averages:

MA(5): 6.53     MA(20): 5.06

MA(100): 5.05     MA(250): 9.24

MACD:

MACD(12,26): 0.49     Signal(12,26,9): 0.22

%K %D:

%K(14,3): 66.87     %D(3): 74.47

RSI:

RSI(14): 69.88

52-Week:

High: 29  Low: 3.4  Change(%): -29.1

Average Vol(K):

3-Month: 2477  10-Days 4502

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.
NTRP has closed below upper band by 11.4%. Bollinger Bands are 70.6% wider than normal. The large width of the bands suggest high volatility as compared to NTRP's normal range. The bands have been in this wide range for 2 bars. This is a sign that the current trend might continue.

Headline News

Thu, 21 Nov 2013 16:49:26 GMT
Neurotrope Inc.

Wed, 03 May 2017 19:30:00 GMT
Neurotrope: A Shameful PR Stunt

Wed, 28 Sep 2016 12:33:33 GMT
Dr. Daniel Alkon Appointed President of Neurotrope, Inc.

Thu, 04 May 2017 20:26:15 GMT
Neurotrope: Lessons Learned

Tue, 06 Sep 2016 12:36:44 GMT
Susanne Wilke, PhD Appointed Chief Executive Officer of Neurotrope, Inc.

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

NA

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Technology

Industry:  Software

Shares Out. (M)

7.90

Shares Float (M)

5.32

% Held by Insiders

14.44

% Held by Institutions

17.37

Shares Short (K)

118

Shares Short Prior Month (K)

108

Stock Financials

EPS

-2.570

EPS Est. Current Year

-1.890

EPS Est. Next Year

-1.960

EPS Est. Next Quarter

-0.460

Forward EPS

-1.958

Book Value (p.s.)

2.470

PEG Ratio

Profit Margin

Operating Margin

Return on Assets (ttm)

-59.5

Return on Equity (ttm)

-106.8

Qtrly Rev. Growth

Gross Profit (p.s.)

Sales Per Share

EBITDA (p.s.)

-1.856

Qtrly Earnings Growth

Operating Cash Flow (M)

-10.75

Levered Free Cash Flow (M)

-4.84

FoxReading.com

Valuation

P/E

-2.63

P/E Growth Ratio

0.01

P/BV

2.73

P/S

P/CF

-4.96

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.